Agilent Technologies, Inc.
A
NYSE·Healthcare·Medical - Diagnostics & Research·Mkt cap $42.6B
$150.84
▲ +0.57%
P/E
29.69
Mkt Cap
$42.6B
52-Wk Range
$108.35–$163.75
52-Week Range
$108.35 - $163.75
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 17.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Advanced technological capabilities
- Comprehensive scientific instrumentation portfolio
- Global research and development infrastructure
- Diversified market presence
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Increasing demand for precision diagnostics
Value
Attractively priced below Life Sciences Tools peer average
Momentum
Strong
+13.7% over 3m
Quality
Strong
Excellent business quality
Dividend
Modest
0.67% yield
Smart-money signal
Who's buying A right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 23, 2026
AUG 26, 2026
Reported EPS of $1.62 vs $1.49 consensus (+8.7% surprise). Revenue of $1.9B vs $1.8B expected (+2.0%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+8.7%
Revenue trend · last 8Q
—
+1%
+6%
+10%
+9%
+7%
+10%
+8%
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
Q3 26
$1.7B
$1.7B
$1.7B
$1.7B
$1.9B
$1.8B
$1.8B
$1.9B
Margins · last 8Q
Gross
0.0%
Operating
23.6%
Profit
19.3%
Wall Street consensus
14 analysts · 79% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
79%
Hold
21%
Sell
0%
Median Price Target
—
Latest: Bernstein · Aug 27, 2026
vs Industry
How A stacks vs Medical - Diagnostics & Research
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related